LTRN
Price
$4.37
Change
-$0.04 (-0.91%)
Updated
Oct 14 closing price
Capitalization
46.98M
21 days until earnings call
Intraday Buy/Sell Signals
ZLDPF
Price
$75.00
Change
-$2.42 (-3.13%)
Updated
Oct 14 closing price
Capitalization
5.4B
Intraday Buy/Sell Signals
Interact to see
Advertisement

LTRN vs ZLDPF

Header iconLTRN vs ZLDPF Comparison
Open Charts LTRN vs ZLDPFBanner chart's image
Lantern Pharma
Price$4.37
Change-$0.04 (-0.91%)
Volume$70.32K
Capitalization46.98M
Zealand Pharma A/S
Price$75.00
Change-$2.42 (-3.13%)
Volume$291
Capitalization5.4B
LTRN vs ZLDPF Comparison Chart in %
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLDPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LTRN vs. ZLDPF commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LTRN is a Hold and ZLDPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (LTRN: $4.37 vs. ZLDPF: $75.00)
Brand notoriety: LTRN and ZLDPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LTRN: 51% vs. ZLDPF: 55%
Market capitalization -- LTRN: $46.98M vs. ZLDPF: $5.4B
LTRN [@Biotechnology] is valued at $46.98M. ZLDPF’s [@Biotechnology] market capitalization is $5.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LTRN’s FA Score shows that 1 FA rating(s) are green whileZLDPF’s FA Score has 2 green FA rating(s).

  • LTRN’s FA Score: 1 green, 4 red.
  • ZLDPF’s FA Score: 2 green, 3 red.
According to our system of comparison, ZLDPF is a better buy in the long-term than LTRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LTRN’s TA Score shows that 4 TA indicator(s) are bullish while ZLDPF’s TA Score has 4 bullish TA indicator(s).

  • LTRN’s TA Score: 4 bullish, 5 bearish.
  • ZLDPF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ZLDPF is a better buy in the short-term than LTRN.

Price Growth

LTRN (@Biotechnology) experienced а -3.96% price change this week, while ZLDPF (@Biotechnology) price change was -5.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

LTRN is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZLDPF($5.4B) has a higher market cap than LTRN($47M). LTRN YTD gains are higher at: 36.991 vs. ZLDPF (-26.729). ZLDPF has higher annual earnings (EBITDA): 7.27B vs. LTRN (-20.48M). ZLDPF has more cash in the bank: 16.6B vs. LTRN (15.9M). LTRN has less debt than ZLDPF: LTRN (145K) vs ZLDPF (397M). ZLDPF has higher revenues than LTRN: ZLDPF (9.11B) vs LTRN (0).
LTRNZLDPFLTRN / ZLDPF
Capitalization47M5.4B1%
EBITDA-20.48M7.27B-0%
Gain YTD36.991-26.729-138%
P/E RatioN/A5.20-
Revenue09.11B-
Total Cash15.9M16.6B0%
Total Debt145K397M0%
FUNDAMENTALS RATINGS
ZLDPF: Fundamental Ratings
ZLDPF
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
19
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
15
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LTRNZLDPF
RSI
ODDS (%)
N/A
Bearish Trend 8 days ago
52%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
63%
Momentum
ODDS (%)
Bullish Trend 8 days ago
86%
Bullish Trend 8 days ago
58%
MACD
ODDS (%)
Bullish Trend 8 days ago
89%
Bullish Trend 8 days ago
61%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 8 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 8 days ago
60%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 14 days ago
74%
Declines
ODDS (%)
Bearish Trend 14 days ago
83%
Bearish Trend 24 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
65%
Aroon
ODDS (%)
Bearish Trend 8 days ago
90%
Bullish Trend 8 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLDPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPHC4.020.05
+1.26%
OptimumBank Holdings Inc
EMN60.540.48
+0.80%
Eastman Chemical Company
ACTG3.420.01
+0.29%
Acacia Research Corp
AESI10.75-0.09
-0.83%
Atlas Energy Solutions
ORCL299.00-9.01
-2.93%
Oracle Corp

ZLDPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDPF has been loosely correlated with IMRN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDPF jumps, then IMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDPF
1D Price
Change %
ZLDPF100%
-3.13%
IMRN - ZLDPF
52%
Loosely correlated
-1.44%
MNMD - ZLDPF
32%
Poorly correlated
+3.02%
VICP - ZLDPF
28%
Poorly correlated
N/A
GLSI - ZLDPF
26%
Poorly correlated
+2.14%
LTRN - ZLDPF
23%
Poorly correlated
-0.91%
More